Search filters

Filters
Clear All

Phase

  • 67
  • 71
  • 1
  • 86
  • 1
  • 60
  • 13
  • 201
  • 576
  • 219
  • 9
  • 25
  • 545
  • 575
  • 4
  • 1
  • 578

Found 579 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

18 years - 99 years
All genders
Phase 3
Interventional
This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.
18 years - 99 years
Accepts healthy volunteer
All genders
Observational
The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including but not limited to frontotemporal dementia (FTD), primary lateral sclerosis (PLS) and progressive muscular atrophy (PMA). More precisely, we want to identify biomarkers of ALS and related diseases. A biomarker …
18 years - 99 years
All genders
Interventional
The purpose of the study is to identify the effects that a “stellate ganglion blockade” has on the electrical and biochemical system of the heart. Eligible participants will be diagnosed ventricular tachycardia and are going to undergo an ablation procedure.
18 years - 99 years
All genders
The research study is being conducted to determine the safety and effectiveness of an investigational device, the Edwards PASCAL Transcatheter Valve Repair System (hereinafter referred to as the PASCAL System), with optimal medical therapy (OMT) compared to optimal medical therapy alone in the treatment of patients with symptomatic, severe tricuspid …
18 years - 85 years
All genders
Interventional
The purpose of this study is to see if a test medicine not yet approved for market, named Rifaximin SSD-40IR given Twice Daily, will help to delay the first episode of overt hepatic encephalopathy (OHE) requiring hospitalization, in patients with liver cirrhosis and how safe it is to use in …
18 years - 99 years
All genders
Phase 1
The purpose of this study is to evaluate an investigational drug called AP-PA02 as a possible treatment for individuals with cystic fibrosis (CF) and chronic pulmonary Pseudomonas aeruginosa (Pa) infection. There are 2 main parts to this study, Part 1 and Part 2. If you choose to take part in …
99 years or below
All genders
A multicentre, non-interventional, post-market registry to collect safety and performance data on all commercially available knitted and woven grafts, and cardiovascular patches. Data will be collected both retrospectively and prospectively.
99 years or below
All genders
A5394 is a phase II, randomized, double-blind, placebo-controlled clinical trial to assess the safety, tolerability, and efficacy of 24 weeks of treatment with Selgantolimod (SLGN). Intensive PK sampling will be conducted in the first 12 participants who enroll into the study.
18 years or above
All genders
Phase 2
Interventional
This study investigates the safety and tolerability of an investigational medication applied to digital ulcers in patients with systemic sclerosis. Systemic sclerosis is a rare condition that causes hard, thickened areas of skin and can affect internal organs and blood vessels.The study focuses on evaluating the safety of the investigational …
 A Randomized  Double-Blind  Parallel  Placebo-Controlled Study of the Efficacy  Safety and Tolerability of Dupilumab in Adult Patients with Active Eosinophilic Esophagitis
1 years - 99 years
All genders
Phase 2
This is a multicenter, randomized, double-blind, placebo-controlled, 2-arm, parallel-group, proof-of-concept study. The primary purpose of this study is to evaluate the effect of dupilumab on relieving EoE clinical symptoms and reducing esophageal inflammation in adults. Currently there is no regulatory-approved endpoint for drug registration for this indication. Published clinical trials …
201 - 210 of 579